Haruaki Ninomiya

Yonago, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Changes in Practitioners' Attitudes toward the Recommendations for Clinical Questions of the Japanese Guideline for Management of Hyperuricemia and Gout, Third Edition between 2018 and 2020 in the Questionnaire's Surveys: Involving Their Attitude toward the New Questionnaires in 2020.

Changes in Practitioners' Attitudes toward the Recommendations for Clinical Questions of the Japanese Guideline for Management of Hyperuricemia and Gout, Third Edition between 2018 and 2020 in the Questionnaire's Surveys: Involving Their Attitude toward the New Questionnaires in 2020.

Journal: JMA journal

Published: December 05, 2024

Prediction for Risk of Hypouricemia in Hospitalized Patients: A Single-center, Retrospective Cohort Study.

Prediction for Risk of Hypouricemia in Hospitalized Patients: A Single-center, Retrospective Cohort Study.

Journal: Internal medicine (Tokyo, Japan)

Published: September 11, 2024

Annual change in eGFR in renal hypouricemia: a retrospective pilot study.

Annual change in eGFR in renal hypouricemia: a retrospective pilot study.

Journal: Clinical and experimental nephrology

Published: March 18, 2024

Azelnidipine protects HL-1 cardiomyocytes from hypoxia/reoxygenation injury by enhancement of NO production independently of effects on gene expression.

Azelnidipine protects HL-1 cardiomyocytes from hypoxia/reoxygenation injury by enhancement of NO production independently of effects on gene expression.

Journal: Heart and vessels

Published: December 05, 2023

CORRIGENDUM: β-Adrenergic Blocker, Carvedilol, Abolishes Ameliorating Actions of Adipose-Derived Stem Cell Sheets on Cardiac Dysfunction and Remodeling After Myocardial Infarction.

CORRIGENDUM: β-Adrenergic Blocker, Carvedilol, Abolishes Ameliorating Actions of Adipose-Derived Stem Cell Sheets on Cardiac Dysfunction and Remodeling After Myocardial Infarction.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: September 24, 2023

Comparison of Recommendations Made by Committee Members with and without Financial Conflict of Interest on Japanese Guideline of Treatment of Hyperuricemia and Gout, Third Edition.

Comparison of Recommendations Made by Committee Members with and without Financial Conflict of Interest on Japanese Guideline of Treatment of Hyperuricemia and Gout, Third Edition.

Journal: JMA journal

Published: May 10, 2023

Impact of Hyper- and Hypo-Uricemia on Kidney Function.

Impact of Hyper- and Hypo-Uricemia on Kidney Function.

Journal: Biomedicines

Published: March 18, 2023

Inhibition of the uric acid efflux transporter ABCG2 enhances stimulating effect of soluble uric acid on IL-1β production in murine macrophage-like J774.1 cells.

Inhibition of the uric acid efflux transporter ABCG2 enhances stimulating effect of soluble uric acid on IL-1β production in murine macrophage-like J774.1 cells.

Journal: Hypertension research : official journal of the Japanese Society of Hypertension

Published: March 01, 2023

Effects of Conditioned Medium of Adipose-Derived Stem Cells Exposed to Platelet-Rich Plasma on the Expression of Endothelial Nitric Oxide Synthase and Angiogenesis by Endothelial Cells.

Effects of Conditioned Medium of Adipose-Derived Stem Cells Exposed to Platelet-Rich Plasma on the Expression of Endothelial Nitric Oxide Synthase and Angiogenesis by Endothelial Cells.

Journal: Annals of plastic surgery

Published: January 23, 2023

Characterization of Urate Metabolism and Complications of Patients with Renal Hypouricemia.

Characterization of Urate Metabolism and Complications of Patients with Renal Hypouricemia.

Journal: Internal medicine (Tokyo, Japan)

Published: November 23, 2022

Xanthinuria Type 1 with a Novel Mutation in Xanthine Dehydrogenase and a Normal Endothelial Function.

Xanthinuria Type 1 with a Novel Mutation in Xanthine Dehydrogenase and a Normal Endothelial Function.

Journal: Internal medicine (Tokyo, Japan)

Published: May 01, 2022

Lactobacillus gasseri PA-3 reduces serum uric acid levels in patients with marginal hyperuricemia.

Lactobacillus gasseri PA-3 reduces serum uric acid levels in patients with marginal hyperuricemia.

Journal: Nucleosides, nucleotides & nucleic acids

Published: March 01, 2022

Showing 1-12 of 61

Last Updated: 09/26/2026